govt.chinadaily.com.cn

Enterprises

SaiLong Pharmaceutical Co

Updated: Apr 16, 2019 govt.chinadaily.com.cn Print
Share - WeChat

赛隆药业.jpg

SaiLong Pharmaceutical Co [Photo/sailong.cn]

Established in 2002, Zhuhai Sailong Pharmaceutical Co mainly focuses on medicine sales in the fields of the nervous, cardiovascular and digestive systems. The company’s R&D centers in Hunan are responsible for work in pharmaceuticals. The company is mainly engaged in cardiovascular and cerebrovascular drugs, such as brain protein hydrolysate for injection. 

The company has built scientific research platforms such as chiral drugs, sustained release drugs and biochemical drugs, with a group of scientific and technical personnel and large precision instruments. The company has successively obtained 11 drug approvals, several drug invention patents, two clinical approvals and more than 10 supplementary research approvals. It has also established features and advantages in R&D into cardiovascular and cerebrovascular, nervous system, new antibiotics, and digestive systems.

At present, the company has built a modern production line for freeze-dried powder needles, small-volume injections, biochemical raw materials and chemical synthetic raw materials. It has a full set of modern production inspection equipment, and has passed many high standards. Its products are sold in 30 provinces, municipalities and autonomous regions.

Add: 2/F, Everbright International Trade Center, Jida district, Zhuhai, Guangdong province

Tel: 860-756-3882970

Website: www.sailong.cn 

Copyright©2024 China Daily. All rights reserved.

京ICP备13028878号-6

京公网安 京公网安备 11010502032503号